Top compounds associated with response to RARS


Feature Type Standardized
Nominal ANOVA
mRNA Panobinostat CTRPv2 pan-cancer AAC -0.2 5e-08
mRNA JNJ-26854165 CTRPv2 pan-cancer AAC -0.2 5e-08
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.18 9e-08
mRNA PX-12 CTRPv2 pan-cancer AAC -0.16 9e-08
mRNA apicidin CTRPv2 pan-cancer AAC -0.17 2e-07
mRNA tacedinaline CTRPv2 pan-cancer AAC -0.2 4e-07
mRNA BRD-A94377914 CTRPv2 pan-cancer AAC -0.23 1e-06
mRNA Cytarabine CTRPv2 pan-cancer AAC -0.15 2e-06
mRNA Docetaxel GDSC1000 pan-cancer AAC 0.15 2e-06
mRNA JQ-1:vorinostat (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.17 3e-06
Download CSV